autoregulatory control of mitochondrial glutathione homeostasis Dual regulation SLC25A39 by AFG3L2 and iron controls homeostasis: Molecular Cell Glutathione synthesis: A two-step pathway.

Lucey, P

Adverse effects observed in trials include: Nausea and vomiting particularly during dose escalation Diarrhoea or constipation Decreased appetite Injection site reactions Fatigue and dizziness Gallbladder-related events (including gallstones), consistent with effects observed with other GLP-1based therapies [9] Rare cases of pancreatitis , a risk associated with the GLP-1 receptor agonist class [10] [3] Because retatrutide is not licensed in the UK, the MHRA has not issued specific prescribing or dosing guidance for this compound

CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability

M.Rodrguez-CarlosA.SerranoC